CLINICAL_TRIALS
trial_result
· 2019-04-16
Clinical Trial Update: A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation [Phase 2]
Summary
Phase 2 trial investigating lorcaserin hydrochloride for smoking cessation has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Arena Pharmaceuticals | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED | Results posted: 2019-04-16